generous in acknowledging that societal arguments against euthanasia have merit and that the rights of individuals have no natural precedence over the rights of society. However, he disputes that the rights of society should necessarily be paramount and takes exception to Lord Walton's 'absolutist' and 'authoritarian' view in proscribing euthanasia.
Yet in a society that advocates personal freedom and respect for autonomy, the issue of infringement of freedoms inherent in the legalization of euthanasia is insufficiently aired. With widespread and equitable availability of high quality palliative care services it is to be hoped that persistent and rational requests for euthanasia might be reduced to a vanishingly small percentage of those with terminal illness. We can never hope to eliminate all such persistent and rational requests. Yet moves to legalize euthanasia would simply serve to promote the autonomy of the minority who retain an interest in ending their lives in this way whilst undermining the freedoms of the majority of society through its unconstrainable potential for abuse, the unrelievable pressure (real or imagined) that it would impose on the vulnerable, and the value that it would irredeemably deny to the elderly, chronically infirm, unproductive and dependent. These malign influences will be real to all who lose their health or are thoughtless and selfish enough simply to become old. Liberty cannot be bought at no cost.
Helme suggests that the Kantian doctrine of treating people invariably as 'ends' and not 'means' is flouted in our denial of the requests of those who seek euthanasia. If the above charges hold some merit, as Helme agrees they do, then legalization of euthanasia extracts a cost from us all and consequently treats the whole of society as a 'means' to the (premature) 'ends' of the few. Lord Walton is right in his stance. Helme's euthanasia tribunals will hardly lessen the societal impact of such legislation.
If we can't have it both ways, how do we choose between the interests of the many and those of the few?
Kilian Dunphy
Medical Director, Hospice of St Francis, 27 Shrublands Road, Berkhamsted, Hertfordshire HP4
3HX, England

Systematic reviews
Lelia Duley's excellent paper (May 1996 jRSM, pp 242-44) carries a gentle warning to anyone doing literature surveys, namely the trap surrounding the belief that 'MED-LINE is the answer to all our needs'. MEDLINE is an excellent literature database which, because of the funding policies of the National Library of Medicine of the National Institutes of Health, is available for little or no cost in the USA and elsewhere. It has therefore become biomedicine's difault database. However, it is an American product tailored to American needs and preferences, and anyone searching the international literature needs to look further.
Numerous studies have looked at the overlap, timeliness, and indexing power of MEDLINE and its competitors. Here it is perhaps sufficient to note that EMBASE, MEDLINE's main competitor which is often dismissed as covering the same journals for more money, in fact covers many titles that MEDLINE does not, with, in some areas, an overlap of only around 40%. EMBASE also tends to change its journal coverage in line with the latest medical trends and, while both do their job well, there is no doubt that searching either database alone is insufficient.
EMBASE is not the only alternative that should be mentioned. Many databases cover areas of biomedicine outside the scope of MEDLINE and, while it cannot be denied that these non-subsidized files cost more, there are many novel ways to access them. Thus, in the UK, many academic institutions have 'bulk contracts' through Bath Information Database Services (BIDS), while users elsewhere have similar opportunities through contracts with database hosts such as DIMDI.
Jack Franklin
Astra b.v., Voorhaven 33, 1135 BL Edam.
The Netherlands
Toxic shock syndrome and burns
Dr Davis and Dr Griffin (February 1996 jRSM, pp 115P-116P) are right to highlight the fact that a burn does not need to be very large for the patient to develop toxic shock syndrome (TSS). Indeed, as they indicate, the classic presentation is of a child with a partial thickness scald too small to require intravenous resuscitation. The point well made by Mr Kay and Mr Surd (July 1996 jRSM, P 420) is that a child with a scald of the size described should have been transferred to a burn centre. The metabolic consequences of the injury demand close attention to fluid management and feeding, as well as to the wound. Such children will usually appear deceptively well on day 3, as did this child, but it is inappropriate to discharge them from hospital unless the home circumstances are first class and the scald is definitely very superficial, which takes a very experienced eye to judge.
The further worry is that minor scalds in children may often be managed in paediatric units of district general hospitals with no input from plastic surgeons. I would not wish to denigrate the valuable work done by paediatricians in the care of minor scalds, nor would I wish to suggest they should all be transferred to bum centres because this would swamp the resources of such centres-the 10% or special areas guideline outlined by Davis and Griffin in their reply is sound. I certainly wish to endorse the main message of the paper, which is that all paediatricians dealing with minor scalds should be aware of the potential for TSS. However, it must also be said that minor scalds, in addition to carrying a risk of TSS, present a significant risk from sepsis and should be considered for early excision and skin grafting. This, if indicated, may minimize infective complications, shorten healing time, and reduce the severity of scarring.
Scalds, unless obviously small and superficial, therefore benefit from early assessment by a plastic surgeon. Paediatricians have long argued that they should be involved in the care of every child admitted to hospital, and doctors caring for burned patients would heartily endorse this sentiment. We would also argue that the reverse is necessary, that no child with a significant burn or scald (say, above 1% body surface area) should be treated in a paediatric unit without a burns-experienced plastic surgeon also being involved in his or her care.
Not every district general hospital is able to provide this dual service, and therefore not every DGH paediatric facility is appropriate for the management of scalds in children.
K Judkins
Chairman, British Burn Association, and Medical Director for Burn Care Services, Pinderfields Hospital, Wakefield, England
Unrecognized hypocalcaemia
The paper by Bellamy and Kendall-Taylor (December 1995 jRSM, pp 690-1), which described a patient with hypoparathyroidism 30 years after almost total thyroidectomy, reminded Cassar (May 1996 jRSM, P 299) of a patient whose hypocalcaemia derived from coeliac disease. I, in my tum was reminded of a patient whose hypocalcaemia had followed partial gastrectomy 14 years before, which had led to vitamin 0 deficiency and osteomalacia from malabsorption with steatorrhoea'. With these, however, there was thirst and polyuria, with hypophosphataemia, raised alkaline phosphatase levels, a renal stone and osteitis fibrosa, diagnosed as secondary hyperparathyroidism because of the hypocalcaemia. On treatment with vitamin D she developed hypercalcaemia that persisted, leading to the removal of a parathyroid adenoma. Vitamin D deficiency had caused hypocalcaemia and masked primary hyperparathyroidism by rendering the plasma-calcium-raising action of parathyroid hormone ineffective.
Milo Keynes
3 Brunswick Walk, Cambridge CBS 8DH, England
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Prenatal screening vouchers
Professor Lilford and Dr Thornton (March 1996jRSM, pp 130-1) rightly point out that we do not know the best methods of allocating resources within the National Health Service and that some secondary preventive procedures, such as prenatal screening, are not taken up by all those who would be entitled to them. They go on to suggest that vouchers for prenatal screening are the only option to prevent those who do not want to use this service from subsidizing those who do. While. their arguments are logical in themselves, there are several pitfalls that would make such a scheme unworkable, cost inefficient, unfair and unethical.
Lilford and Thornton suggest that the value of the voucher should be adjusted to be equivalent to the cost of the test to the health service, 'taking into acount the health service savings from preventing handicap'. With this approach the voucher would have a negative value if the test in question were cost effective as far as total health service costs were concerned. Determining the value of the voucher would be difficult, since different health care providers might offer different packages of prenatal testing. Even identical packages could have different values depending on the qualifications and expertise of those who are performing the tests. As health care providers contract out more procedures (such as pathological analysis) the differences in the value of vouchers are likely to become greater.
Calculating the savings for care providers would be equally difficult since the costs of providing a health care service are not proportional to the number of individual services provided. Personnel costs account for the highest proportion of expenses of any health care provider and unless personnel are reduced the savings to the health service from not doing a test are likely to be smaller than the costs of administering the voucher system. Reducing personnel may not be an option as some prenatal screening should be provided by the health service even if it is not taken up by the majority of potential users.
Lilford and Thornton rightly state that not all health care providers or users can agree on the value of a test. To assign a monetary value to it might be even more difficult-at the very least it could be an expensive procedure.
To further analyse the appropriateness of vouchers for prenatal testing one has to assume that a monetary value could be assigned to the vouchers and that regional differences could be overcome by an elaborate (and expensive) accounting system. The value of the voucher would constitute a certain percentage of the expendable income of an individual family. It might be equivalent to 3 weeks' expendable income in a poor family or less than I days' expendable income in a rich family. The cost, adjusted for family income, of having a test would therefore be higher for a low income family than for a high income family.
The ethical problems of a voucher scheme would be extremely complex. Assuming a health service user had converted the voucher to cash, would the mother and her child then still be entitled to any potential intervention which could have been prevented had the voucher been used for a prenatal screening test? Example: a mother decides to cash in her antibody test vouchers. At 32 weeks an ultrasound scan is performed for suspected polyhydramnios and fetal hydrops is diagnosed. Will the fetus and baby, who have not participated in the decision not to have screening, still be entitled to therapy if the hydrops is caused by rhesus antibodies?
In view of the practical, economic, common sense and ethical problems of a potential voucher scheme it might be wise to shelve the idea in obstetrics until it has been tested in other areas such as chemotherapy for relapse of disseminated ovarian cancer.
R Pitroff
Maternal and Child Epidemiology Unit, London
School of Hygiene and Tropical Medicine, London WC1E 7HT, England
What do patients want from Medical research?
Robin Fox's splendid editorial (june 1996 jRSM, pp 301~2) stimulated me to a reprehensible practice-self-advertisement. A recent paper had asked the same important question', an earlier one? having proposed a new way to answer it which continues to engage our attention. In fact, more and more methods are being developed that not only allow clinicians to listen to their individual patients-" but also enable use to be made of what is learned in this way to treat the self-same individual. Such information about outcomes is also highly relevant to evidence-based medicine (EBM), and so may help to build a bridge between EBM and complementary methods. One of these is the subject of Andrew Vickers' excellent review in the same issue(pp 301--11).
C R B Joyce
Royal College of Surgeons in Ireland, Dublin 2, Ireiand
